£76.06

Springer Treatment with Gallopamil: Results of recent research on calcium antagonism

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£76 today · usual range £0–£0 · best ever £72

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 627 days • 627 data points (No recent data available)

Historical
Generating forecast...
£76.68 £71.24 £72.42 £73.61 £74.80 £75.99 £77.18 10 June 2024 13 November 2024 19 April 2025 22 September 2025 26 February 2026

Price Distribution

Price distribution over 627 days • 4 price levels

Days at Price
Current Price
451 days 111 days 11 days · current 54 days 0 113 226 338 451 £72 £73 £76 £77 Days at Price

Price Analysis

Most common price: £72 (451 days, 71.9%)

Price range: £72 - £77

Price levels: 4 different prices over 627 days

Description

Calcium antagonists are currently the most extensively investigated drugs for the treatment of heart disease. They are used worldwide with great success and a comparatively low incidence of adverse reactions. The most prevalent and threatening diseases in modem industrialized societies - the various forms and complications of coronary arteriosclerosis and arterial hypertension - are amenable to treatment with calcium antagonists. The pharmacological spectrum of calcium antagonists is highly specific and was supplemen ted a few years ago by gallopamil, a verapamil analogue. The experimental work reported at this symposium was concerned with effects of gallopamil on the electrophysiology of the heart, particularly in acute myocardial ischemia. New therapeutic features of myocardial hypertrophy and hypertrophic cardiomyopathy are discussed. In medical practice, gallopa mil has proved particularly useful for the treatment of angina pectoris. Studies comparing gallopamil with other calcium antagonists are described to profile the properties of the drugs in terms of their specific therapeutic value. There is still a need for more differential therapeutic trials. This first international symposium on gallopamil was attended by experts from institutions devoted to theoretical and clinical research and general practice.

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
16 December 2011
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Amlodipine
96% match

Amlodipine

Springer

£84.74 20 Feb 2026
Therapie und Prävention mit Kalziumantagonisten: Hypertonie ― Koronare Herzkrankheit ― Arteriosklerose
95% match

Therapie und Prävention mit Kalziumantagonisten: Hypertonie ― Koronare Herzkrankheit ― Arteriosklerose

Springer

£43.02 07 Apr 2026
Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (Pharmacology Research Safety T) (Pharmacology - Research, Safety Testing and Regulation)
94% match

Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (Pharmacology Research Safety T) (Pharmacology - Research, Safety Testing and Regulation)

£252.99 27 Feb 2026
Calcium-Antagonisten
94% match

Calcium-Antagonisten

Springer

£46.95 12 Apr 2026
Calcium Ion Modulators: The New Wave of Pschotropic Drugs
94% match

Calcium Ion Modulators: The New Wave of Pschotropic Drugs

CRC Press

£157.08 11 Jan 2026
Calcium: The molecular basis of calcium action in biology and medicine
94% match

Calcium: The molecular basis of calcium action in biology and medicine

Springer

£167.95 02 Feb 2026
Calcium: The molecular basis of calcium action in biology and medicine
94% match

Calcium: The molecular basis of calcium action in biology and medicine

Springer

£171.54 10 Mar 2026
The Emergence of Drugs which Block Calcium Entry: 6 (Progress in Clinical Biochemistry and Medicine, 6)
94% match

The Emergence of Drugs which Block Calcium Entry: 6 (Progress in Clinical Biochemistry and Medicine, 6)

Springer

£74.11 25 Feb 2026
The ESC Handbook on Cardiovascular Pharmacotherapy (The European Society of Cardiology Series)
94% match

The ESC Handbook on Cardiovascular Pharmacotherapy (The European Society of Cardiology Series)

Oxford University Press

£45.00 12 Jan 2026
Autonome Innervation des Herzens Myokardiale Hypoxie
94% match

Autonome Innervation des Herzens Myokardiale Hypoxie

Springer

£39.94 07 Mar 2026
Modulation of Cardiac Calcium Sensitivity: A New Approach to Increasing the Strength of the Heart (Oxford Medical Publications)
94% match

Modulation of Cardiac Calcium Sensitivity: A New Approach to Increasing the Strength of the Heart (Oxford Medical Publications)

Oxford University Press

£115.00 02 Mar 2026
Wege zu neuen Arzneimitteln: Geschichte der Hochdruckforschung bei Bayer
94% match

Wege zu neuen Arzneimitteln: Geschichte der Hochdruckforschung bei Bayer

Springer

£55.87 19 Feb 2026
Biochemistry of Signal Transduction in Myocardium: 17 (Developments in Molecular and Cellular Biochemistry, 17)
93% match

Biochemistry of Signal Transduction in Myocardium: 17 (Developments in Molecular and Cellular Biochemistry, 17)

Springer

£245.57 13 Jan 2026
Myocardial Ischemia and Arrhythmia: Under the auspices of the Society of Cooperation in Medicine and Science (SCMS), Freiburg, Germany
93% match

Myocardial Ischemia and Arrhythmia: Under the auspices of the Society of Cooperation in Medicine and Science (SCMS), Freiburg, Germany

Springer

£76.62 25 Feb 2026
Nimodipine: Pharmacological and Clinical Results in Cerebral Ischemia
93% match

Nimodipine: Pharmacological and Clinical Results in Cerebral Ischemia

Springer

£88.52 15 Feb 2026
Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Cardiovascular Remodeling: Volume 147 (Progress in Molecular Biology and Translational Science, Volume 147)
93% match

Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Cardiovascular Remodeling: Volume 147 (Progress in Molecular Biology and Translational Science, Volume 147)

Academic Press

£111.49 10 Mar 2026
Pulmonary Arterial Hypertension & Nifedipine
93% match

Pulmonary Arterial Hypertension & Nifedipine

Nova Science Publishers Inc

£104.99 19 Apr 2026
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... in Cardiovascular Medicine, 100)
93% match

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... in Cardiovascular Medicine, 100)

Springer

£125.69 03 Mar 2026
Biophysical Basis of Physiology and Calcium Signaling Mechanism in Cardiac and Smooth Muscle
93% match

Biophysical Basis of Physiology and Calcium Signaling Mechanism in Cardiac and Smooth Muscle

Academic Press

£98.59 05 Apr 2026
Voltage-gated Ca2+ Channels: Pharmacology, Modulation and their Role in Human Disease: 279 (Handbook of Experimental Pharmacology, 279)
93% match

Voltage-gated Ca2+ Channels: Pharmacology, Modulation and their Role in Human Disease: 279 (Handbook of Experimental Pharmacology, 279)

£111.85 10 Jan 2026
Calcium Channels: Properties, Functions and Regulation (Cerebrovascular Research & Disorders Series) (Cerebrovascular Research and Disorders: Physiology-laboratory and Clinical Research)
93% match

Calcium Channels: Properties, Functions and Regulation (Cerebrovascular Research & Disorders Series) (Cerebrovascular Research and Disorders: Physiology-laboratory and Clinical Research)

£52.04 01 Mar 2026
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... in Cardiovascular Medicine, 100)
93% match

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on ... in Cardiovascular Medicine, 100)

Springer

£140.51 05 Mar 2026
Calcium Entry Channels in Non-Excitable Cells (Methods in Signal Transduction Series)
93% match

Calcium Entry Channels in Non-Excitable Cells (Methods in Signal Transduction Series)

CRC Press

£103.48 12 Feb 2026
Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy (Volume 148) (Progress in Molecular Biology and Translational Science, Volume 148)
93% match

Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy (Volume 148) (Progress in Molecular Biology and Translational Science, Volume 148)

Academic Press

£112.29 11 Mar 2026